Investigational Study For Small Cell Lung Cancer Patients Using Radiation
Seeking Men and Women 18 years or older who have small cell lung cancer, which can spread to the brain.
9 Studies found
Lung Cancer
Lung Cancer
Experimental Study For Treating Patients With Non-Small Cell Lung Cancer (Alchemist)
Seeking Men and Women over 18 years old who have early stage non-small cell lung cancer that was surgically removed and may have been treated with chemotherapy and/or radiation. The tumor removed has a mutation of a gene called EGFR (Epidermal Growth Factor Receptor).
Lung Cancer
Study For Patients With Early Stage Non-Small Cell Lung Cancer (Alchemist 4512)
Seeking adult men & women whose tumor cells have a change in a gene called ALK that causes the cells to grow and spread.
Lung Cancer
Investigational Drug Study, Involving Radiation for Patients with Lung Cancer.
Seeking Men and Women over 18 years old who have a certain type of Stage III Non-Small Cell Lung Cancer (NSCLC).
Lung Cancer
Study Of Using Tumor Biomarkers To Guide Treatment For Non-Small Cell Lung Cancer
Seeking adults with non-small cell lung cancer for a study comparing immunotherapy to targeted therapy based on tumor characteristics
Lung Cancer
Study Of An Investigational Drug For Non-Small Cell Lung Cancer That Has Spread
People with non-small cell lung cancer that has spread outside their lungs and whose tumor has a particular biomarker are sought for a study of an investigational drug.
Lung Cancer
Study Of Immunotherapy Alone Or In Combination With Chemotherapy For Advanced Nonsquamous Non-Small Cell Lung Cancer
Non-squamous non-small cell lung cancer patients whose cancer has been tested to be PD-L1 positive (a kind of tumor marker) sought for study comparing two usual approaches to treatment.
Lung Cancer
Study Of An Investigational Drug For Previously Treated Non-Small Cell Lung Cancer
Seeking volunteers who received immunotherapy, but whose non-small cell lung cancer has spread outside their lungs and either their tumor sample biomarker does not match one of the open treatment studies or they were not a candidate for a biomarker-matched study for a study of an investigational drug combination.
Lung Cancer
Addition Of An Investigational Drug To The Usual Treatment For Limited Stage Small Cell Lung Cancer (Ls-Sclc)
Men and women with limited-stage small cell lung cancer, which has not spread outside of their chest area sought for a study comparing how cancer responds when adding an investigational drug to the usual treatment for small cell lung cancer